We won't get coronavirus vaccine results in October

We won't get coronavirus vaccine results in October
Hollis Johnson/Business Insider


Today in healthcare news: The door has closed on getting vaccine data in October, and Eli Lilly ends its antibody trial in hospitalized COVID-19 patientswhile the US is paying $375 million for 300,000 vials of the investigational drug.

Plus: A timeline of Trump's coronavirus statements matched with new cases over the course of the pandemic.

Pfizer's CEO repeatedly talked up getting coronavirus vaccine data in October. Now, he's asking for patience.

  • Pfizer CEO Albert Bourla effectively closed the door Tuesday on knowing whether or not its experimental coronavirus vaccine would work by the end of October.
  • On the New York pharma giant's third quarter earnings call, Bourla acknowledged the company has not yet started the first interim analysis for this final study, called a phase-three trial.
  • In September, Bourla set public expectations for an October data readout, a timeline at odds with top government scientists like Dr. Anthony Fauci and Moncef Slaoui, Operation Warp Speed's chief scientist.
  • Instead, Bourla asked on Tuesday for patience, as the study progresses.

Read the full story from Andrew Dunn here>>


Eli Lilly has ended a major COVID-19 antibody test among hospitalized patients

Read the full story from Allana Akhtar here>>

A timeline of Trump's statements about the coronavirus juxtaposed with new cases throughout the pandemic

See the full chart from Susie Neilson and Yuqing Liu here>> More stories we're reading:

- Lydia